tiprankstipranks
No major surprises from Neurocrine presentation, says JPMorgan
PremiumThe FlyNo major surprises from Neurocrine presentation, says JPMorgan
17d ago
Trump Trade: New administration to invest $20B to build data centers
Premium
The Fly
Trump Trade: New administration to invest $20B to build data centers
23d ago
Neurocrine price target raised to $162 from $142 at UBS
Premium
The Fly
Neurocrine price target raised to $162 from $142 at UBS
23d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
Top 3 Trending Stocks, According to Analysts – 12/18/2024  
Premium
Market News
Top 3 Trending Stocks, According to Analysts – 12/18/2024  
1M ago
Neurocrine announces FDA approval of crenessity
Premium
The Fly
Neurocrine announces FDA approval of crenessity
2M ago
Neurocrine Biosciences’ $300M Share Buyback Plan: Potential Risks and Market Volatility Concerns
PremiumCompany AnnouncementsNeurocrine Biosciences’ $300M Share Buyback Plan: Potential Risks and Market Volatility Concerns
3M ago
Neurocrine Biosciences Reports Strong Q3 2024 Earnings
Premium
Company Announcements
Neurocrine Biosciences Reports Strong Q3 2024 Earnings
3M ago
Neurocrine reports Q3 non-GAAP EPS $1.81, consensus $1.50
Premium
The Fly
Neurocrine reports Q3 non-GAAP EPS $1.81, consensus $1.50
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100